MG4101

ex vivo expanded allogeneic NK cell therapy · Samsung Medical Center

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for MG4101, covering 2015-12-03 to 2023-04-18. Get the full timeline:

Most recent: Clinical Trial Update: MG4101 for Refractory or Relapsed AML [Phase 2]